CIK 0001005286 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 05/25
| FY2024 | FY2023 | FY2021 | FY2020 | |
|---|---|---|---|---|
| Revenue (USD) | ||||
| Net income (USD) | -32.3 M | 411000 | 24.8 M | |
| Diluted EPS (USD/shares) | -3.32 | -1.1 | 0.01 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-20 | 8-K | 8-K items 8.01 | 2026-10-16 |
| 2026-09-29 | SCHEDULE 13D/A | SCHEDULE 13D/A | |
| 2026-09-29 | 8-K | 8-K items 1.01,9.01 | 2026-09-24 |
| 2026-09-28 | SCHEDULE 13D/A | SCHEDULE 13D/A | |
| 2026-09-28 | DEFA14A | DEFA 14A | |
| 2026-09-28 | 8-K | 8-K items 1.01,7.01,9.01 | 2026-09-27 |
| 2026-08-05 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-05 | 8-K | 8-K items 2.02,7.01,9.01 | 2026-08-05 |
| 2026-07-29 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-07-02 | SCHEDULE 13D/A | SCHEDULE 13D/A | |
| 2026-07-02 | 8-K | 8-K items 7.01 | 2026-06-29 |
| 2026-07-02 | SCHEDULE 13D/A | SCHEDULE 13D/A | |
| 2026-06-08 | 4 | OWNERSHIP DOCUMENT | 2026-06-04 |
| 2026-06-05 | 4 | FORM 4 | 2026-06-04 |
| 2026-06-05 | 4 | FORM 4 | 2026-06-04 |
| 2026-06-05 | 4 | FORM 4 | 2026-06-04 |
| 2026-06-05 | 4 | FORM 4 | 2026-06-04 |
| 2026-06-05 | 4 | FORM 4 | 2026-06-04 |
| 2026-06-05 | 4 | FORM 4 | 2026-06-04 |
| 2026-06-05 | 4 | FORM 4 | 2026-06-04 |
| 2026-06-05 | 8-K | 8-K items 5.02,5.07,9.01 | 2026-06-04 |
| 2026-05-21 | 4 | FORM 4 | 2026-05-20 |
| 2026-05-06 | 10-Q | 10-Q | 2026-03-31 |
| 2026-05-06 | 8-K | 8-K items 2.02,7.01,9.01 | 2026-05-06 |
| 2026-04-27 | SCHEDULE 13G/A | SCHEDULE 13G/A |
Forms on file (last 1,000): 4 489, 8-K 190, SC 13G/A 54, 10-Q 42, 3 31, SC 13D/A 25, 4/A 22, DEF 14A 16. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=LFCR (0.002 USD), /gw/filings/filings?ticker=LFCR&form=8-K, /gw/filings/facts?ticker=LFCR&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange